Join to View Full Profile
Merck, Box 1000UG3c-054North Wales, PA 19454
Phone+1 267-305-7590
Dr. Connor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified psychiatrist with special interest in treating adults with anxiety disorders, with training in psychopharmacology and mindfulness-based practices. Currently, I am working in the pharmaceutical industry and not in formal practice.
Education & Training
Duke University HospitalResidency, Psychiatry, 1994 - 1997
Wellspan Health/York HospitalInternship, Internal Medicine, 1993 - 1994
University of Maryland School of MedicineClass of 1993
Certifications & Licensure
MD State Medical License 1999 - 2016
Publications & Presentations
PubMed
- 21 citationsEffects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 data.W. Joseph Herring, Kathryn M. Connor, Ellen Snyder, Duane B. Snavely, Charles M. Morin
Sleep Medicine. 2017-12-01 - 19 citationsPhase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.Kathryn M. Connor, Paulette Ceesay, Jill Hutzelmann, Duane B. Snavely, Andrew D. Krystal
The International Journal of Neuropsychopharmacology. 2017-08-01 - 47 citationsSuvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical TrialsW. Joseph Herring, Kathryn M. Connor, Ellen Snyder, Duane B. Snavely, Ying Zhang
The American Journal of Geriatric Psychiatry. 2017-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
